M42 Health
James Sibley has a vast experience in the financial and healthcare sectors, holding various board member positions and executive roles in companies such as Cleveland Clinic Abu Dhabi, M42 Health, and United Eastern Medical Services (UEMedical). With a background in transaction services and mergers and acquisitions, James also worked as a Senior Manager at PwC Middle East and Manager at PwC UK. James holds a degree in Economics from the University of Reading and is a Certified Board Director in Corporate Governance from INSEAD.
This person is not in any teams
This person is not in any offices
M42 Health
14 followers
M42 is an Abu Dhabi-based, global tech-enabled healthcare company operating at the forefront of medical advancement. The company is seeking to transform lives through innovative clinical solutions that can solve the world’s most critical health and diagnostic challenges. By harnessing unique medical and data-centric technologies, including genomics and AI, M42 is transforming the traditional healthcare ecosystem and delivering the highest level of precise, patient-centric, and preventative care. M42 has over 20,000 employees and more than 450 facilities in 26 countries around the world. M42 owns a wide portfolio of assets that includes Amana Healthcare, Biogenix Labs, Danat Al Emarat, Diaverum, HealthPoint Hospital, the HealthPlus network of specialty centers, Moorfields Eye Hospital Abu Dhabi, Imperial College London Diabetes Centre, Insights Research Organization & Solutions (IROS), Omics Center of Excellence and National Reference Laboratory, among others.